Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(10%)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
5
50%
Ph phase_2
1
10%
Ph phase_3
2
20%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Terminated(1)
Other(7)

Detailed Status

unknown7
Not yet recruiting1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (12.5%)
Phase 32 (25.0%)
N/A5 (62.5%)

Trials by Status

not_yet_recruiting110%
terminated110%
recruiting110%
unknown770%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10